Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies

A method for performing active immunotherapy for an allergic disease, comprising the step of administering to a subject a prophylactically or therapeutically effective amount of a molecule or molecule complex comprising a TLR9 binding part capable of binding to TLR9, a CD32 binding part capable of binding to CD32, and at least one epitope of at least one antigen, wherein the allergic disease in the subject is treated or prevented.